- call +1-201-465-4211
- email sales@mrinsights.biz
Scope of the Report:
This report studies the Biosimilars/follow-on-biologics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biosimilars/follow-on-biologics market by product type and applications/end industries.
Biosimilars or follow-on-biologics are the “copied” and licensed versions of those reference biologics that have undergone patent expiration. Biosimilars development and validation with reference biologics is a crucial aspect of the overall development process.
The global Biosimilars/follow-on-biologics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biosimilars/follow-on-biologics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Novartis (Sandoz)
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck Serono (Merck)
Biogen idec
Genentech (Roche)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
Market Segment by Applications, can be divided into
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Biosimilars/follow-on-biologics Market Overview
1.1 Product Overview and Scope of Biosimilars/follow-on-biologics
1.2 Classification of Biosimilars/follow-on-biologics by Types
1.2.1 Global Biosimilars/follow-on-biologics Revenue Comparison by Types (2017-2023)
1.2.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Types in 2017
1.2.3 Human growth hormone
1.2.4 Erythropoietin
1.2.5 Monoclonal antibodies
1.2.6 Insulin
1.2.7 Interferon
1.2.8 Granulocyte-Colony Stimulating Factor
1.2.9 Others
1.3 Global Biosimilars/follow-on-biologics Market by Application
1.3.1 Global Biosimilars/follow-on-biologics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Blood disorders
1.3.3 Oncology diseases
1.3.4 Chronic and autoimmune diseases
1.3.5 Growth hormone deficiencies
1.3.6 Others
1.4 Global Biosimilars/follow-on-biologics Market by Regions
1.4.1 Global Biosimilars/follow-on-biologics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Biosimilars/follow-on-biologics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biosimilars/follow-on-biologics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biosimilars/follow-on-biologics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Biosimilars/follow-on-biologics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biosimilars/follow-on-biologics Status and Prospect (2013-2023)
1.5 Global Market Size of Biosimilars/follow-on-biologics (2013-2023)
2 Manufacturers Profiles
2.1 Novartis (Sandoz)
2.1.1 Business Overview
2.1.2 Biosimilars/follow-on-biologics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Synthon Pharmaceuticals
2.2.1 Business Overview
2.2.2 Biosimilars/follow-on-biologics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Teva Pharmaceutical Industries
2.3.1 Business Overview
2.3.2 Biosimilars/follow-on-biologics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)
2.4 LG Life Sciences
2.4.1 Business Overview
2.4.2 Biosimilars/follow-on-biologics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 LG Life Sciences Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Celltrion Biocon
2.5.1 Business Overview
2.5.2 Biosimilars/follow-on-biologics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Hospira
2.6.1 Business Overview
2.6.2 Biosimilars/follow-on-biologics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Hospira Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck Serono (Merck)
2.7.1 Business Overview
2.7.2 Biosimilars/follow-on-biologics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Biogen idec
2.8.1 Business Overview
2.8.2 Biosimilars/follow-on-biologics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biogen idec Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Genentech (Roche)
2.9.1 Business Overview
2.9.2 Biosimilars/follow-on-biologics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biosimilars/follow-on-biologics Market Competition, by Players
3.1 Global Biosimilars/follow-on-biologics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Biosimilars/follow-on-biologics Players Market Share
3.2.2 Top 10 Biosimilars/follow-on-biologics Players Market Share
3.3 Market Competition Trend
4 Global Biosimilars/follow-on-biologics Market Size by Regions
4.1 Global Biosimilars/follow-on-biologics Revenue and Market Share by Regions
4.2 North America Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
4.3 Europe Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
4.5 South America Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
5 North America Biosimilars/follow-on-biologics Revenue by Countries
5.1 North America Biosimilars/follow-on-biologics Revenue by Countries (2013-2018)
5.2 USA Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
5.3 Canada Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
5.4 Mexico Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
6 Europe Biosimilars/follow-on-biologics Revenue by Countries
6.1 Europe Biosimilars/follow-on-biologics Revenue by Countries (2013-2018)
6.2 Germany Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
6.3 UK Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
6.4 France Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
6.5 Russia Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
6.6 Italy Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Biosimilars/follow-on-biologics Revenue by Countries
7.1 Asia-Pacific Biosimilars/follow-on-biologics Revenue by Countries (2013-2018)
7.2 China Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
7.3 Japan Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
7.4 Korea Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
7.5 India Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
8 South America Biosimilars/follow-on-biologics Revenue by Countries
8.1 South America Biosimilars/follow-on-biologics Revenue by Countries (2013-2018)
8.2 Brazil Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
8.3 Argentina Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
8.4 Colombia Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Biosimilars/follow-on-biologics by Countries
9.1 Middle East and Africa Biosimilars/follow-on-biologics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
9.3 UAE Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
9.4 Egypt Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
9.6 South Africa Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
10 Global Biosimilars/follow-on-biologics Market Segment by Type
10.1 Global Biosimilars/follow-on-biologics Revenue and Market Share by Type (2013-2018)
10.2 Global Biosimilars/follow-on-biologics Market Forecast by Type (2018-2023)
10.3 Human growth hormone Revenue Growth Rate (2013-2023)
10.4 Erythropoietin Revenue Growth Rate (2013-2023)
10.5 Monoclonal antibodies Revenue Growth Rate (2013-2023)
10.6 Insulin Revenue Growth Rate (2013-2023)
10.7 Interferon Revenue Growth Rate (2013-2023)
10.8 Granulocyte-Colony Stimulating Factor Revenue Growth Rate (2013-2023)
10.9 Others Revenue Growth Rate (2013-2023)
11 Global Biosimilars/follow-on-biologics Market Segment by Application
11.1 Global Biosimilars/follow-on-biologics Revenue Market Share by Application (2013-2018)
11.2 Biosimilars/follow-on-biologics Market Forecast by Application (2018-2023)
11.3 Blood disorders Revenue Growth (2013-2018)
11.4 Oncology diseases Revenue Growth (2013-2018)
11.5 Chronic and autoimmune diseases Revenue Growth (2013-2018)
11.6 Growth hormone deficiencies Revenue Growth (2013-2018)
11.7 Others Revenue Growth (2013-2018)
12 Global Biosimilars/follow-on-biologics Market Size Forecast (2018-2023)
12.1 Global Biosimilars/follow-on-biologics Market Size Forecast (2018-2023)
12.2 Global Biosimilars/follow-on-biologics Market Forecast by Regions (2018-2023)
12.3 North America Biosimilars/follow-on-biologics Revenue Market Forecast (2018-2023)
12.4 Europe Biosimilars/follow-on-biologics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Biosimilars/follow-on-biologics Revenue Market Forecast (2018-2023)
12.6 South America Biosimilars/follow-on-biologics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Biosimilars/follow-on-biologics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Biosimilars/follow-on-biologics Picture
Table Product Specifications of Biosimilars/follow-on-biologics
Table Global Biosimilars/follow-on-biologics and Revenue (Mil
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
